Physician profile

Brian Maxfield

Anesthesiology · Maywood, IL

NPI 1184042533

$5,597.18

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,374.86

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $3,645.43 2019-2024 Proclaim, Eterna
Relievant Medsystems, INC. $925.17 2021
Boston Scientific Corporation $789.49 2020-2023 Wavewriter Alpha Prime 16
Spinal Simplicity, LLC $99.04 2023 Ha Minuteman G3-R
Nalu Medical, INC. $62.27 2024 Nalu Neurostimulation System
Foundation Fusion Solutions, LLC $43.20 2024
Cardiovascular Systems INC. $32.58 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Brian Maxfield

$5,597.18

in general payments reported 2019-2025

Years
2019-2024
Top company
Abbott Laboratories

https://glasscript.com/doctor/5700755/brian-maxfield

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.